Achieve Life Sciences Inc

NAS:ACHVHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$6.61+3.53%At closeAt close · Tue 20 Oct · ≈ AED 24.26 · Market cap $679.67M · Next earnings Thu 5 Nov · Extended $6.60 −0.08%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−39.3%	−118.2%	−510.1%	2,059.0%	−190.6%	−254.0%	−254.0%	+0.0 pts
Return on assets	−36.4%	−69.8%	−141.3%	−153.9%	−103.1%	−130.8%	−130.8%	+0.0 pts
Return on capital employed	−39.5%	−77.0%	−487.3%	1,889.7%	−122.3%	−167.8%	—	—
Debt / equity	0.0×	0.5×	2.0×	−11.6×	0.5×	0.7×	0.7×	+0.0%
Debt / assets	0.4%	31.6%	54.0%	86.4%	25.8%	35.8%	—	—
Interest coverage	0.0×	0.0×	−22.8×	−9.6×	−17.9×	−67.0×	—	—
Current ratio	12.6×	9.8×	1.3×	0.8×	5.5×	4.4×	4.4×	+0.0%
Quick ratio	12.6×	9.8×	1.3×	0.8×	5.5×	4.4×	—	—
Cash ratio	12.2×	9.5×	1.1×	0.7×	1.9×	2.3×	2.3×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	—	0.0×	0.0×	0.0×	—	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—